All Stories

  1. The IOTA ADNEX is the best approach to the characterisation of ovarian masses
  2. Typical ultrasound features of various endometrial pathology described using the International Endometrial Tumor Analysis (IETA) terminology in women with abnormal uterine bleeding
  3. ISUOG Consensus Statement on rationalization of gynecological ultrasound services in context of  SARS‐CoV ‐2
  4. ISUOG Consensus Statement on rationalization of early‐pregnancy care and provision of ultrasonography in context of SARS‐CoV ‐2
  5. Peri‐implantation urinary hormone monitoring distinguishes between types of first‐trimester spontaneous pregnancy loss
  6. Evaluation of tramline sign for prenatal diagnosis of abnormally invasive placenta using three‐dimensional ultrasound and Crystal Vue rendering technology
  7. Differences in ultrasound features of papillations in unilocular-solid adnexal cysts: a retrospective international multicenter study
  8. Ultrasound characteristics of endometrial cancer as defined by International Endometrial Tumor Analysis (IETA) consensus nomenclature: prospective multicenter study
  9. Ambulatory versus inpatient management of severe nausea and vomiting of pregnancy: a randomised control trial with patient preference arm
  10. We need to change the culture around complaints procedures
  11. Doctors’ perception of support and the processes involved in complaints investigations and how these relate to welfare and defensive practice: a cross-sectional survey of the UK physicians
  12. OP30.11: The first trimester fetal central nervous system: a novel ultrasonographic perspective
  13. EP22.23: Novel three-dimensional imaging of the fetal kidneys in the first trimester
  14. OP11.07: The natural history of pregnancy-related enhanced myometrial vascularity (EMV)
  15. OP15.02: Use of Crystal Vue technique for imaging of adnexal masses: a pilot study
  16. P09.07: Three-dimensional imaging of the fetal skeletal system at 9 weeks' gestation
  17. OC08.06: * Association of vaginal microbiota composition and outcomes in women found to have a pregnancy of unknown location (PUL) on an initial early pregnancy ultrasound scan
  18. OP11.06: Diagnostic protocols for the management of pregnancy of unknown location (PUL): a systematic review and meta-analysis
  19. OC19.05: The tramline sign for abnormally invasive placenta using Crystal Vue with flow
  20. OP11.05: Predictors of the successful expectant management of tubal ectopic pregnancy
  21. OP11.08: The management of recurrent ectopic pregnancy: a multicentre observational study
  22. OP11.02: Endometrial thickness and its value in triaging women with a pregnancy of unknown location
  23. OC04.05: Pelvic ultrasonography of patients awaiting uterine transplantation: the UK cohort
  24. The first-trimester fetal central nervous system: a novel ultrasonographic perspective
  25. Factors to consider in pregnancy of unknown location
  26. Validation of the Performance of International Ovarian Tumor Analysis (IOTA) Methods in the Diagnosis of Early Stage Ovarian Cancer in a Non-Screening Population
  27. Validation of a virtual reality simulator for the use of transvaginal ultrasonography in gynaecology and early pregnancy
  28. Clinical Utility of Risk Models to Refer Patients with Adnexal Masses to Specialized Oncology Care: Multicenter External Validation Using Decision Curve Analysis
  29. First International Consensus Report on Adnexal Masses: Management Recommendations
  30. Can risk factors, clinical history and symptoms be used to predict risk of ectopic pregnancy in women attending an early pregnancy assessment unit?
  31. Post-traumatic stress, anxiety and depression following miscarriage or ectopic pregnancy: a prospective cohort study
  32. Managing pregnancy of unknown location based on initial serum progesterone and serial serum hCG levels: development and validation of a two-step triage protocol
  33. Evaluation of Pregnancy Viability
  34. Evaluating the risk of ovarian cancer before surgery using the ADNEX model: a multicentre external validation study
  35. Refining Ovarian Cancer Test accuracy Scores (ROCkeTS): protocol for a prospective longitudinal test accuracy study to validate new risk scores in women with symptoms of suspected ovarian cancer
  36. Psychological morbidity associated with hyperemesis gravidarum: a systematic review and meta-analysis
  37. Systematic approach to sonographic evaluation of the pelvis in women with suspected endometriosis, including terms, definitions and measurements: a consensus opinion from the International Deep Endometriosis Analysis (IDEA) group
  38. Age-related differences in the sonographic characteristics of endometriomas
  39. Doctors' experiences and their perception of the most stressful aspects of complaints processes in the UK: an analysis of qualitative survey data
  40. The clinical performance of the M4 decision support model to triage women with a pregnancy of unknown location as at low or high risk of complications
  41. Cutting GMC investigations must not simply devolve problems elsewhere
  42. Interobserver agreement in assessment of polycystic ovarian morphology using pattern recognition
  43. Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group
  44. Morcellation and risk of malignancy in presumed ovarian fibromas/fibrothecomas
  45. Why greater emphasis must be given to getting the diagnosis right: the example of miscarriage
  46. Authors’ reply to Fountain and colleagues
  47. Defining safe criteria to diagnose miscarriage: prospective observational multicentre study
  48. OP08.04: Validation of a virtual reality simulator for the use of transvaginal ultrasonography in gynecology and early pregnancy
  49. OC24.07: Use of endoscopic laser speckle contrast analysis to assess uterine perfusion and blood flow in a uterine transplantation model
  50. OC13.05: Assessing uterine graft viability using multispectral imaging during uterine transplantation
  51. OC16.01: Pain and ultrasonographic appearance of endometriomas may change with age
  52. Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) group
  53. Reply: Diagnostic and management modalities in early tubal pregnancy with focus on safety
  54. The role of ultrasonography in the diagnosis and management of early pregnancy complications
  55. Diagnosing adnexal tumours before surgery: a critical appraisal of recent evidence
  56. Accuracy of ultrasonography performed by examiners with varied training and experience in predicting specific pathology of adnexal masses
  57. A spline-based tool to assess and visualize the calibration of multiclass risk predictions
  58. Dharmasena case illustrates what is wrong with complaints procedures
  59. The impact of complaints procedures on the welfare, health and clinical practise of 7926 doctors in the UK: a cross-sectional survey
  60. 218: Standardized fetal growth curves according to world health organization recommendations (GAMLSS analysis) in a low-risk caucasian population
  61. Pregnancy of Unknown Location
  62. NICE guidance on place of birth falls short of neutrality
  63. A missed opportunity for excellence: the NICE guideline on the diagnosis and initial management of ectopic pregnancy and miscarriage
  64. The characteristic ultrasound features of specific types of ovarian pathology (Review)
  65. Authors' reply to Candido-dos-Reis
  66. Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study
  67. Prognostic Value of Serum HE4 Levels and Risk of Ovarian Malignancy Algorithm Scores at the Time of Ovarian Cancer Diagnosis
  68. OP16.04: User satisfaction with the Clinical Data Miner electronic data capture software
  69. Automated classification of static ultrasound images of ovarian tumours based on decision level fusion
  70. Reply: Niche risk factor for uterine rupture?
  71. Imaging techniques for the pre-surgical diagnosis of adnexal tumours
  72. UKEPSS: The UK Early Pregnancy Surveillance Service for uncommon disorders of early pregnancy and acute gynaecology
  73. Use of a pocket-sized ultrasound machine (PUM) for routine examinations in the third trimester of pregnancy
  74. Strategies to diagnose ovarian cancer: new evidence from phase 3 of the multicentre international IOTA study
  75. Automatic segmentation and classification of gestational sac based on mean sac diameter using medical ultrasound image
  76. Letter to the Editor JMIG on the Article “Cesarean scar defects: an underrecognized cause of abnormal uterine bleeding and other gynecologic complications” (2013;20; 562-572)
  77. Discovery and characterization of olokizumab
  78. Prevalence, potential risk factors for development and symptoms related to the presence of uterine niches following Cesarean section: systematic review
  79. Triaging pregnancies of unknown location: the performance of protocols based on single serum progesterone or repeated serum hCG levels
  80. Diagnostic Criteria for Nonviable Pregnancy Early in the First Trimester
  81. Diagnostic Criteria for Nonviable Pregnancy Early in the First Trimester
  82. Do Women with Pain and Bleeding in Early Pregnancy Require a Vaginal Speculum Examination as Part of Their Assessment?
  83. Ectopic pregnancy prediction in women with a pregnancy of unknown location: data beyond 48 h are necessary
  84. Presurgical diagnosis of adnexal tumours using mathematical models and scoring systems: a systematic review and meta-analysis
  85. Are serum HE4 or ROMA scores useful to experienced examiners for improving characterization of adnexal masses after transvaginal ultrasonography?
  86. Normative data for uterine size according to age and gravidity and possible role of the classical golden ratio
  87. Screening for data clustering in multicenter studies: the residual intraclass correlation
  88. Diagnostic Criteria for Nonviable Pregnancy Early in the First Trimester
  89. Diagnosing ectopic pregnancy and current concepts in the management of pregnancy of unknown location
  90. External validation of models and simple scoring systems to predict miscarriage in intrauterine pregnancies of uncertain viability
  91. Defining the relationship between fetal Doppler indices, abdominal circumference and growth rate in severe fetal growth restriction using functional linear discriminant analysis
  92. Differentiating stage I epithelial ovarian cancer from benign disease in women with adnexal tumors using biomarkers or the ROMA algorithm
  93. A multicenter prospective external validation of the diagnostic performance of IOTA simple descriptors and rules to characterize ovarian masses
  94. Shotgun Proteomics Identifies Serum Fibronectin as a Candidate Diagnostic Biomarker for Inclusion in Future Multiplex Tests for Ectopic Pregnancy
  95. Reply
  96. Reply
  97. The influence of weight gain patterns in pregnancy on fetal growth using cluster analysis in an obese and nonobese population
  98. Predicting successful vaginal birth after Cesarean section using a model based on Cesarean scar features examined by transvaginal sonography
  99. Multicentre external validation of IOTA prediction models and RMI by operators with varied training
  100. A comparison between an ultrasound based prediction model (LR2) and the Risk of Ovarian Malignancy Algorithm (ROMA) to assess the risk of malignancy in women with an adnexal mass
  101. Changes in Cesarean section scar dimensions during pregnancy: a prospective longitudinal study
  102. Does the presence of a Caesarean section scar affect implantation site and early pregnancy outcome in women attending an early pregnancy assessment unit?
  103. NICE guidance on ectopic pregnancy and miscarriage restricts access and choice and may be clinically unsafe
  104. Phase 4 of the International Ovarian Tumour Analysis study group: To compare the referral pattern and cost-effectiveness of using Risk of Malignancy Index (RMI) versus Logistic Regression model (LR2) to diagnose adnexal masses prior to surgery
  105. Rationalizing the management of pregnancies of unknown location: temporal and external validation of a risk prediction model on 1962 pregnancies
  106. Improving strategies for diagnosing ovarian cancer: a summary of the International Ovarian Tumor Analysis (IOTA) studies
  107. Impact of ovulation and implantation timing on first-trimester crown-rump length and gestational age
  108. Imaging in gynecological disease (7): clinical and ultrasound features of Brenner tumors of the ovary
  109. When is a pregnancy nonviable and what criteria should be used to define miscarriage?
  110. Visibility and measurement of Cesarean section scars in pregnancy: a reproducibility study
  111. Clinically oriented three-step strategy for assessment of adnexal pathology
  112. Does the presence of a Cesarean section scar influence the site of placental implantation and subsequent migration in future pregnancies: a prospective case-control study
  113. Accurate prediction of pregnancy viability by means of a simple scoring system
  114. Changes seen in the ultrasound features of a presumed decidualised ovarian endometrioma mimicking malignancy
  115. Preoperative identification of a suspicious adnexal mass
  116. Detection of intracavitary uterine pathology using offline analysis of three-dimensional ultrasound volumes: interobserver agreement and diagnostic accuracy
  117. Managing early pregnancy loss: diagnosing miscarriage is not as easy at you might think
  118. Ectopic Pregnancy
  119. OC03.01: *Do pocket-sized ultrasound machines correlate well in measurements with high specification ultrasound machines?
  120. OP05.06: External validation of a simple ultrasound based scoring system to predict pregnancy viability beyond the first trimester
  121. OP11.01: Interobserver variability in the ultrasound diagnosis of congenital uterine anomalies
  122. P20.11: How different ultrasound machine-transducer combinations affect early pregnancy calculations
  123. OP11.04: Interobserver variability in the ultrasound diagnosis of polycystic ovaries using pattern recognition
  124. OP36.02: Do pocket-sized ultrasound machines have the potential to be used as a tool to triage patients in obstetrics and gynecology?
  125. OC14.01: Changes in Cesarean section scar dimensions during pregnancy: a prospective longitudinal study
  126. OP20.07: The diagnosis of focal uterine intracavitary lesions and endometrial cancer in women with abnormal uterine bleeding
  127. OP32.02: Relationship between ovulation-implantation interval, first trimester crown-rump length, birth weight and gestation at delivery
  128. OP05.02: Improved performance of a model and simple scoring system to predict outcome of intrauterine pregnancy of uncertain viability: an external validation study
  129. P16.06: Longitudinal condition specific fetal growth charts in antiphospholipid syndrome and systemic lupus erythematosus
  130. OP25.02: The clinical implications of machine-transducer combinations on nuchal translucency measurement
  131. P20.10: Do variations between axial and lateral calliper measurements affect calculation of gestational sac measurements in early pregnancy?
  132. Key findings from the International Ovarian Tumor Analysis (IOTA) study: an approach to the optimal ultrasound based characterisation of adnexal pathology
  133. Do pocket-sized ultrasound machines have the potential to be used as a tool to triage patients in obstetrics and gynecology?
  134. Standardized Approach for Imaging and Measuring Cesarean Section Scars Using Ultrasonography
  135. Ultrasound assessment of the peri-implantation uterus: a review
  136. Characterizing Ovarian Pathology
  137. A Mathematical Model for Interpretable Clinical Decision Support with Applications in Gynecology
  138. Triaging women with ovarian masses for surgery: observational diagnostic study to compare RCOG guidelines with an International Ovarian Tumour Analysis (IOTA) group protocol
  139. Limitations of Current Definitions of Miscarriage Using Mean Gestational Sac Diameter and Crown-Rump Length Measurements
  140. Reply
  141. Reply
  142. Standardized approach for imaging and measuring Cesarean section scars using ultrasonography
  143. Improved modeling of clinical data with kernel methods
  144. The Role of Ultrasound in Gynaecology
  145. Pregnancy of unknown viability or location: less is more in the majority of cases
  146. External Validation of Diagnostic Models to Estimate the Risk of Malignancy in Adnexal Masses
  147. Performance of the American College of Obstetricians and Gynecologistsʼ Ovarian Tumor Referral Guidelines With a Multivariate Index Assay
  148. Umbilical artery pulsatility index and fetal abdominal circumference in isolated gastroschisis
  149. Clinical implications of intra- and interobserver reproducibility of transvaginal sonographic measurement of gestational sac and crown-rump length at 6-9 weeks' gestation
  150. Limitations of current definitions of miscarriage using mean gestational sac diameter and crown-rump length measurements: a multicenter observational study
  151. Gestational sac and embryonic growth are not useful as criteria to define miscarriage: a multicenter observational study
  152. Three-dimensional image of a tubal heterotopic pregnancy following assisted reproduction treatment
  153. OC14.01: Using a model based on serum biochemistry at 4 and 5 weeks gestation to predict immediate viability and viability at 12 weeks in IVF pregnancies
  154. OC17.01: The association of patients' characteristics and bleeding pattern with uterine intracavitary pathology
  155. OC26.05: Longitudinal measurements of Caesarean section scar size and residual myometrial thickness in pregnancy as predictors of scar appearance at repeat Caesarean delivery
  156. OP02.07: Behaviour of serum hormone levels at 4 and 5 weeks gestation in an IVF treatment population
  157. OP10.08: The relationship between previous elective or emergency Caesarean section and time-to-next-pregnancy interval on Caesarean scar size and residual myometrial thickness in subsequent pregnancy
  158. OP33.07: How is the orientation and magnitude of a CRL measurement used to estimate fetal gestation affected by ultrasound machines variability?
  159. P25.02: How do different ultrasound machines affect fetal gestation estimations from gestation sac measurements?
  160. OC21.04: A prediction model to distinguish between benign, borderline, stage I invasive, higher stage invasive, and metastatic adnexal tumors
  161. OC04.05: The limitations of using mean gestation sac diameter (MSD) measurements to define miscarriage
  162. OC04.02: Longitudinal growth of crown-rump length, gestation sac and yolk sac in pregnancies following fertility treatment
  163. OC20.05: Changes in Caesarean section scar size in the three trimesters of pregnancy
  164. OC04.04: The appearance of an embryo with or without visible heartbeat and yolk sac in small gestation sacs in accurately dated fertility treatment patients
  165. OP33.03: Visibility and dimensions of Caesarean section scars in pregnancy-an interobserver variability study
  166. OC21.02: Selection of women with an ovarian tumor for surgery in specialist centers: a comparison of two triaging protocols
  167. OP25.02: The influence of maternal body mass index and subsequent weight gain pattern on fetal growth
  168. A Novel Approach to Predict the Likelihood of Specific Ovarian Tumor Pathology Based on Serum CA-125: A Multicenter Observational Study
  169. Effect of gel-instillation sonography on Doppler ultrasound findings in endometrial polyps
  170. Ectopic pregnancy
  171. A model and scoring system to predict outcome of intrauterine pregnancies of uncertain viability
  172. Pregnancy of unknown location: a consensus statement of nomenclature, definitions, and outcome
  173. Effect of cancer prevalence on the use of risk-assessment cut-off levels and the performance of mathematical models to distinguish malignant from benign adnexal masses
  174. One-stop gynaecology
  175. Is Serum Human Chorionic Gonadotrophin Follow-Up Necessary after Suspected Spillage of Trophoblast at the Time of Laparoscopic Surgery for Ectopic Pregnancy?
  176. Ectopic pregnancy: using the hCG ratio to select women for expectant or medical management
  177. Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group
  178. Improving the preoperative classification of adnexal masses as benign or malignant by second-stage tests
  179. Polytomous diagnosis of ovarian tumors as benign, borderline, primary invasive or metastatic: development and validation of standard and kernel-based risk prediction models
  180. Reply: No influence of body mass index on first trimester fetal growth
  181. OC08.01: Differentiation of uterine pathology by transvaginal elastography: preliminary results
  182. OP29.06: Umbilical artery PI and fetal abdominal circumference in gastroschisis
  183. OC01.03: Ultrasound in diagnosis of new and recurrent borderline ovarian tumors
  184. OC04.03: Risk factors for tubal versus non-tubal ectopic pregnancies: a multicentre case series
  185. OC04.05: A longitudinal assessment of gestation sac growth in pregnancies subsequently shown to be viable and non-viable
  186. OC04.02: Intra- and inter-observer reproducibility of first trimester measurements between 6 and 9 weeks gestation
  187. OC04.04: The influence of pre-pregnancy BMI and maternal weight gain in pregnancy on fetal size at 12 weeks: a cross sectional analysis
  188. OC05.01: Reducing the follow-up required in women with a failing pregnancy of unknown location
  189. OC05.07: Gestation sac shape, sub-chorionic haematoma and vaginal bleeding as predictors of viability in intrauterine pregnancies of uncertain viability (IPUV)
  190. P16.01: Comparing tubal and non-tubal ectopic pregnancies: a multicentre case series
  191. P16.04: The influence of symptoms, uncertainty of dates and previous miscarriage on gestation sac growth
  192. OC23.04: Which adnexal masses are difficult to classify as benign or malignant with prediction models?
  193. OP02.11: The effect of BMI on first trimester CRL growth: a longitudinal analysis
  194. P02.03: Longitudinal growth of MSD and CRL in intrauterine pregnancies of uncertain viability (IPUV) and its relationship to gestation sac shape
  195. OP07.02: The added value of fluid instillation sonography in women with a total endometrial thickness ⩽ 5 mm at transvaginal ultrasound
  196. OP07.04: The value of fluid instillation sonography in women under 40 years of age
  197. OP02.10: Prediction of pregnancy viability by means of scoring systems: towards a ‘risk of miscarriage’ index
  198. OC23.02: Which histologies limit the ability of CA-125 to characterize adnexal masses? An observational study of 3511 patients
  199. OP02.09: Variations in the standard of care of women with ectopic pregnancy
  200. Does a prediction model for pregnancy of unknown location developed in the UK validate on a US population?
  201. The relationship between first trimester fetal growth, pregnancy-associated plasma protein A levels and birthweight
  202. No influence of body mass index on first trimester fetal growth
  203. New crown-rump length curve based on over 3500 pregnancies
  204. The viability of the intrauterine pregnancies in the pregnancy of unknown location population: hCG ratio vs progesterone
  205. Endometriomas: their ultrasound characteristics
  206. Reply
  207. Ovarian cancer prediction in adnexal masses using ultrasound-based logistic regression models: a temporal and external validation study by the IOTA group
  208. Accuracy of peritoneal fluid measurements by transvaginal ultrasonography
  209. Prospective external validation of the ‘ovarian crescent sign’ as a single ultrasound parameter to distinguish between benign and malignant adnexal pathology
  210. Acoustic streaming cannot discriminate reliably between endometriomas and other types of adnexal lesion: a multicenter study of 633 adnexal masses
  211. Ultrasound Experience Substantially Impacts on Diagnostic Performance and Confidence when Adnexal Masses Are Classified Using Pattern Recognition
  212. Terms, definitions and measurements to describe the sonographic features of the endometrium and intrauterine lesions: a consensus opinion from the International Endometrial Tumor Analysis (IETA) group
  213. Characterising pelvic masses using ultrasound
  214. Rationalising acute gynaecology services: is it time to move away from ‘stand-alone’ early pregnancy units?
  215. Diagnosis and management of ovarian cyst accidents
  216. Ultrasound methods to distinguish between malignant and benign adnexal masses in the hands of examiners with different levels of experience
  217. Applying a British mathematical model to predict the outcome of pregnancy of unknown location in a United States population
  218. OP24.06: Elastography in gynecology: preliminary experience
  219. OP10.02: The influence of body mass index on first trimester fetal growth
  220. OC01.02: What measurements are needed to classify pregnancies of unknown location?
  221. P19.03: The relationship between early first trimester PAPP-A and birthweight percentiles
  222. OC11.02: Prediction of intracavity uterine pathology at ultrasound examination using off-line analysis
  223. OC25.02: Intercenter variability in ultrasound features of malignant and benign adnexal masses
  224. OC11.01: Comparison of gel instillation sonography (GIS) with unenhanced ultrasound in the diagnosis of uterine intracavity lesions
  225. OC07.01: A new crown-rump length curve based on over 3500 pregnancies
  226. OC05.01: Predicting ovarian malignancy if simple rules are not applicable
  227. OP30.08: The influence of gel-infusion on the vascularity of endometrial polyps
  228. OP27.07: The relationship between abdominal circumference and umbilical artery Doppler z-scores in severe early onset fetal growth restriction
  229. OP30.01: Interobserver agreement on reporting uterine intracavity lesions at gel infusion sonography (GIS)
  230. OP10.01: The influence of maternal demographic features on fetal size in the first trimester
  231. OP10.09: The relationship between fetal growth in the first trimester, PAPP-A and birthweight percentiles
  232. OP08.02: Crown-rump length in genetically abnormal pregnancies compared to a CRL curve for normal pregnancies
  233. OC07.04: The value of assessment of patient history and pain and bleeding scores prior to early pregnancy transvaginal ultrasound assessment
  234. P20.02: The relationship between abdominal circumference and middle cerebral artery Doppler z-scores in severe early onset fetal growth restriction
  235. OC01.04: A practical approach to preoperatively assess ovarian pathology: combining pattern recognition and mathematical models
  236. Adding a single CA 125 measurement to ultrasound imaging performed by an experienced examiner does not improve preoperative discrimination between benign and malignant adnexal masses
  237. OC05.03: The natural history over eleven years of ovarian pathology characterized as dermoid cysts using transvaginal ultrasonography
  238. Diagnosis of ectopic pregnancy with ultrasound
  239. Pregnancies of unknown location
  240. Management strategies for hyperemesis
  241. Diagnosing miscarriage
  242. Taking the management of early-pregnancy complications seriously
  243. Dating and growth in the first trimester
  244. Twin growth discrepancy in early pregnancy
  245. The use of serum inhibin A and activin A levels in predicting the outcome of 'pregnancies of unknown location'
  246. An application of methods for the probabilistic three-class classification of pregnancies of unknown location
  247. The optimal timing of an ultrasound scan to assess the location and viability of an early pregnancy
  248. Pregnancy of unknown location
  249. Why Are Some Ectopic Pregnancies Characterized as Pregnancies of Unknown Location at the Initial Transvaginal Ultrasound Examination?
  250. Functional linear discriminant analysis: a new longitudinal approach to the assessment of embryonic growth
  251. Assessing first trimester growth: the influence of ethnic background and maternal age
  252. A scoring system to differentiate malignant from benign masses in specific ultrasound-based subgroups of adnexal tumors
  253. The use of transvaginal ultrasonography to diagnose bladder carcinoma in women presenting with postmenopausal bleeding
  254. Reliability of transvaginal ultrasonography at 7-9 weeks' gestation in the determination of chorionicity and amnionicity in twin pregnancies
  255. Predicting Outcomes in Pregnancies of Unknown Location
  256. Evidence of early first-trimester growth restriction in pregnancies that subsequently end in miscarriage
  257. OP12.06: Optimal timing of transvaginal ultrasound to confirm early pregnancy viability
  258. OC162: Presence of acoustic streaming in different types of adnexal masses
  259. OC144: Prospective evaluation of logistic regression models to predict malignancy of adnexal masses prior to surgery
  260. OC097: Pregnancy location and viability in women with chlamydia trachomatis infection
  261. OC089: Utilizing hCG ratio to reduce the number of visits in the pregnancy of unknown location (PUL) population
  262. OC092: The appearance and behaviour of ectopic pregnancies in the ‘pregnancy of unknown location’ population
  263. OC096: How important is measuring endometrial thickness in women with pregnancies of unknown location?
  264. OP09.02: A cross-sectional analysis of embryonic growth in normal and genetically abnormal pregnancies
  265. OC107: Growth delay in the first trimester: Sensitivity and specificity of using serial measurements of embryonic growth for the prediction of early pregnancy loss
  266. OC147: Confirming the limited role of CA-125 for adnexal mass diagnosis
  267. OC001: Prospective assessment of simple rules to distinguish between malignant and benign adnexal masses prior to surgery
  268. OP14.02: The influence of maternal age on early first trimester growth assessed by ultrasound
  269. OC153: Prospective evaluation of a model to diagnose adnexal masses as benign, primary invasive, borderline, or metastatic
  270. OC146: Multicenter prospective testing to predict malignancy in adnexal masses using Bayesian network models
  271. OC091: Can high definition transvaginal ultrasound result in a reduction in the number of women characterised as having a pregnancy of unknown location?
  272. OP14.01: Assessing early first trimester growth with ultrasonography: The influence of ethnic background
  273. OC112: Determination of outcome in very early intrauterine pregnancies of uncertain viability
  274. OC152: Prevalence of cancer and optimal cut-off levels for mathematical models to distinguish between benign and malignant adnexal masses
  275. OP17.01: Prospective comparison of one-step and two-step models for the classification of adnexal masses as benign or malignant
  276. OC094: The timing of serum human chorionic gonadotrophin measurements to predict the outcome of pregnancies of unknown location
  277. OC145: Ultrasound scoring system to differentiate benign from malignant masses in specific subgroups of adnexal tumors
  278. OC109: Validation of the Robinson growth curve with data of transvaginal ultrasound assessments in early pregnancy from a large Caucasian population
  279. OC021: Assessment of pattern recognition for the ultrasound diagnosis of an endometrioma
  280. OC150: Investigation of the performance of mathematical models on small ovarian masses in the IOTA phase 1 and 2 study
  281. OC090: The use of serial measurements of inhibin A and activin A to predict the outcome of pregnancies of unknown location
  282. The hCG ratio can predict the ultimate viability of the intrauterine pregnancies of uncertain viability in the pregnancy of unknown location population
  283. Multi-class AUC metrics and weighted alternatives
  284. Towards a Clinical Decision Support System for Pregnancies of Unknown Location
  285. Simple ultrasound-based rules for the diagnosis of ovarian cancer
  286. The role of ultrasound in investigating abnormal uterine bleeding
  287. In Reply
  288. Chlamydia trachomatisinfection in patients attending an Early Pregnancy Unit: Prevalence, symptoms, pregnancy location and viability
  289. Why are some ectopic pregnancies characterized as pregnancies of unknown location at the initial transvaginal ultrasound examination?
  290. Discrimination Between Benign and Malignant Adnexal Masses by Specialist Ultrasound Examination Versus Serum CA-125
  291. The diagnostic effectiveness of an initial transvaginal scan in detecting ectopic pregnancy
  292. OP04.07: Predicting early pregnancy loss with functional linear discriminant analysis (FLDA)
  293. OC156: CA-125 does not add to and is not superior to pattern recognition for discrimination between benign and malignant adnexal masses
  294. OC48: Development of a model to predict ability of ultrasound to make a diagnosis at first assessment in the unselected early pregnancy population
  295. OC69: Ability to make a diagnosis at first early pregnancy ultrasound assessment according to gestational age
  296. OC63: Why are some ectopic pregnancies missed on the initial ultrasound examination?
  297. OC59: A single transvaginal ultrasound examination as a test for ectopic pregnancy
  298. OC67: Persisting pregnancies of unknown location: challenges in diagnosis and management
  299. OC58: Ectopic pregnancy diagnosis and management: a 4-year experience
  300. OP17.03: The impact of a two-week referral rapid access ultrasound-based clinic to assess women considered at high-risk of gynecological malignancy
  301. OC65: Anechoic free peritoneal fluid in early intrauterine pregnancy
  302. OC64: Pain does not predict ultrasound diagnosis of ectopic pregnancy in the Early Pregnancy Unit
  303. OC46: Does discrepancy between expected and measured crown-rump length in the early first trimester predict subsequent miscarriage?
  304. OP04.01: Has ultrasound eliminated the need for a vaginal speculum examination in the assessment of women with bleeding in early pregnancy?
  305. OP05.02: Can transvaginal ultrasound at 7-9 weeks reliably diagnose chorionicity and amnionicity in twin pregnancies?
  306. OP04.08: Does the location of a subchorionic hematoma in early pregnancy affect the miscarriage rate?
  307. OC47: Discrepancy in crown-rump length between twins as a predictor of spontaneous embryonic demise to a singleton pregnancy
  308. OC66: Quantification of the amount of vaginal bleeding to predict early pregnancy ultrasound diagnosis and outcome to 12 weeks
  309. Clinical information does not improve the performance of mathematical models in predicting the outcome of pregnancies of unknown location
  310. Inclusion of CA-125 Does Not Improve Mathematical Models Developed to Distinguish Between Benign and Malignant Adnexal Tumors
  311. The simple outpatient management of Bartholin's abscess using the Word catheter: A preliminary study
  312. Rationalizing the follow-up of pregnancies of unknown location
  313. Reply: Ultrasound diagnosis of ectopic pregnancy
  314. Prospective cross-validation of three methods of predicting failing pregnancies of unknown location
  315. Comparing Methods for Multi-class Probabilities in Medical Decision Making Using LS-SVMs and Kernel Logistic Regression
  316. Prediction of ectopic pregnancy in women with a pregnancy of unknown location
  317. The accuracy of first trimester ultrasound in the diagnosis of hydatidiform mole
  318. A validation of the most commonly used protocol to predict the success of single-dose methotrexate in the treatment of ectopic pregnancy
  319. The nonsurgical management of ectopic pregnancy
  320. Handbook of Early Pregnancy Care
  321. Transvaginal Sonographic Diagnosis of Appendicitis in Acute Pelvic Pain
  322. OC166: The pre-operative characterisation of ovarian pathology using serum CA125 and ultrasonography
  323. OC165: Shortcomings of serum CA125 in diagnosing ovarian cancer
  324. P18.14: Transvaginal ultrasonography and saline infusion sonography compared with outpatient hysteroscopy for the diagnosis of endometrial polyps and submucous fibroids
  325. OC20: Validation of a logistic regression model to predict the outcome of pregnancies of unknown location in a new patient population
  326. OC19: Using a mathematical model in the management of pregnancies of unknown location: a prospective interventional study
  327. OC18: What is the optimal approach to classifying viable intra-uterine pregnancies in the PUL population?
  328. OC17: Ultrasound and not biochemistry determines the ultimate viability of intra-uterine pregnancies in the PUL population
  329. OC54: Do women with hyperemesis gravidarum need an ultrasound scan?
  330. OP15.06: The value of ultrasound for the diagnosis of gestational trophoblastic disease
  331. OP15.07: A potential new approach to the monitoring and management of Cesarean scar ectopic pregnancies
  332. There is no role for uterine curettage in the contemporary diagnostic workup of women with a pregnancy of unknown location
  333. Hyperemesis gravidarum: is an ultrasound scan necessary?
  334. The Use of Ultrasound-Based ???Soft Markers??? for the Prediction of Pelvic Pathology in Women With Chronic Pelvic Pain???Can We Reduce the Need for Laparoscopy?
  335. General obstetrics: Failing pregnancies of unknown location: a prospective evaluation of the human chorionic gonadotrophin ratio
  336. Predicting the outcome of pregnancies of unknown location: Bayesian networks with expert prior information compared to logistic regression
  337. Do early pregnancy ultrasound measurements correlate with fetal nuchal translucency at 11–14 weeks?
  338. The use of ultrasound-based 'soft markers' for the prediction of pelvic pathology in women with chronic pelvic pain-can we reduce the need for laparoscopy?
  339. The practical application of a mathematical model to predict the outcome of pregnancies of unknown location
  340. Pregnancies of unknown location: consensus statement
  341. Impact of the availability of sonography in the acute gynecology unit
  342. The conservative management of cervical ectopic pregnancies
  343. The non-surgical management of ectopic pregnancy
  344. Pregnancies of unknown location: diagnostic dilemmas and management
  345. Diagnostic accuracy of varying discriminatory zones for the prediction of ectopic pregnancy in women with a pregnancy of unknown location
  346. Logistic Regression Model to Distinguish Between the Benign and Malignant Adnexal Mass Before Surgery: A Multicenter Study by the International Ovarian Tumor Analysis Group
  347. OC16.01: The pros and cons of using mathematical models to predict malignancy in ovarian masses
  348. OC37.01: Is it safe to perform uterine curettage in women with no signs of an intra-uterine pregnancy on transvaginal ultrasound?
  349. OC31.08: What is the optimal approach to accurately classifying failing pregnancies of unknown location (PULs)?
  350. P12.03: Can we improve the performance of logistic regression analysis for predicting the outcome of pregnancies of unknown location (PULs)?
  351. P12.10: Is it possible to predict successful treatment response to methotrexate earlier than seven days?
  352. OC31.03: The role of ultrasound in acute gynaecology and its impact on management
  353. OC31.07: Can the hCG ratio be used to predict likelihood of success of conservative management of ectopic pregnancies?
  354. OC31.05: Prevalence of pathology in women presenting with pelvic pain and/or bleeding to an inner London acute gynaecology unit (AGU)
  355. OC31.04: Can the ultrasonographic appearance of an ectopic pregnancy determine the likelihood of success for conservative management?
  356. P12.07: The value of transvaginal sonography in surgical evacuation of retained products of conception
  357. Do levels of serum cancer antigen 125 and creatine kinase predict the outcome in pregnancies of unknown location?
  358. Do we need to follow up complete miscarriages with serum human chorionic gonadotrophin levels?
  359. Evidence-based principles and practices in pathology: selected problem areas
  360. The accuracy of transvaginal ultrasonography for the diagnosis of ectopic pregnancy prior to surgery
  361. A prospective evaluation of a single-visit strategy to manage pregnancies of unknown location
  362. The role of ultrasound in the management of the acute gynaecological abdomen
  363. Ectopic pregnancy deaths: what should we be doing?
  364. Ultrasound and endoscopic surgery in obstetrics and gynaecology. A combined and treatment . By D Timmerman, J Deprest and T Bourne, pp xxiv + 344, 2003 (Springer-Verlag, Berlin, Heidelberg, New York), £125.00 ISBN 3-540-76212-4
  365. The conservative management of interstitial pregnancy
  366. P04.10: A new logistic regression model for predicting ectopic pregnancies based on a single visit
  367. OC040: The use of a logistic regression model to predict ectopic pregnancies in an early pregnancy setting
  368. P04.13: Conservative management of cervical ectopic pregnancy
  369. OC041: Pregnancies of unknown location: a new logistic regression model for predicting outcome
  370. OC134: Can we safely manage more tubal ectopic pregnancies conservatively?
  371. P04.11: Can serum creatine kinase and CA 125 levels be used to predict the outcome in pregnancies of unknown location?
  372. P04.12: Can clinical factors and ultrasonographic findings be useful in the prediction of outcome in pregnancies of unknown location (PUL)?
  373. P04.30: Ultrasound and the polycystic ovary-are sonographic indices any predictor of endocrinopathy? A pilot study
  374. OC038: A prospective evaluation of a single visit strategy to manage pregnancies of unknown location (PUL)
  375. Human chorionic gonadotrophin and progesterone levels in pregnancies of unknown location
  376. Should we be examining the ovaries in pregnancy? Prevalence and natural history of adnexal pathology detected at first-trimester sonography
  377. The use of a new logistic regression model for predicting the outcome of pregnancies of unknown location
  378. The management of ectopic pregnancies and pregnancies of unknown location
  379. The role of transvaginal ultrasound in the management of abnormal uterine bleeding
  380. Book review
  381. Preface
  382. The conservative management of early pregnancy complications: a review of the literature
  383. The role of ultrasound in the management of menorrhagia
  384. Single-dose methotrexate in the treatment of cornual pregnancies diagnosed with ultrasound in the first trimester
  385. The positive pregnancy test and an empty uterus—the use of a new logistic regression model for predicting the outcome of pregnancies of unknown location
  386. Are ultrasound and biochemical indices useful in the management of pregnancies of unknown location?
  387. First-trimester ultrasound: is a single-visit strategy in pregnancies of unknown location safe?
  388. Does a normal scan exclude the presence of significant pathology in women with chronic pelvic pain?
  389. The use of ultrasound to diagnose polycystic ovaries. An analysis of interobserver variability
  390. Should ectopic pregnancy always be visualised using transvaginal ultrasonography?
  391. Is ultrasound an essential part of the examination when attending the emergency room with possible gynaecological pathology? A prospective evaluation
  392. The role of ultrasound in the emergency room—the prevalence of pathology and impact on management in the gynaecology patient
  393. Should we be examining the ovaries in pregnancy? The natural history of adnexal pathology detected at first-trimester ultrasonography
  394. Subjective assessment of pregnancies of unknown location with the use of serial biochemistry: an analysis of interobserver variability and experience
  395. Is the diagnosing of polycystic ovaries on ultrasound useful? The relationship between clinical symptoms and ovarian morphology
  396. Placental site trophoblastic tumor masquerading as an ovarian ectopic pregnancy
  397. Results from an ultrasound-based familial ovarian cancer screening clinic: a 10-year observational study
  398. P022: The correlation between early pregnancy ultrasound measurements and fetal nuchal translucency
  399. OC020: Is the discriminatory zone an outdated concept?
  400. Ultrasound and Endoscopic Surgery in Obstetrics and Gynaecology
  401. Ultrasound of the Ovary
  402. Ultrasound and Menorrhagia
  403. Amenorrhoea and Polycystic Ovarian Syndrome
  404. Ultrasound Characteristics of Endometriosis
  405. The Assessment of Tubal Patency: Hystero-Contrast-Salpingography
  406. Ultrasound Diagnosis and Management of Miscarriage
  407. The Use of Ultrasound to Assess the Morphology of Ovarian Tumours
  408. Ultrasound Diagnosis and Management of Pregnancy of Unknown Location and Ectopic Pregnancy
  409. P119: Transvaginal ultrasound based soft markers: inter-observer variability and experience
  410. OC065: Negative predictive value of transvaginal ultrasound in women with chronic pelvic pain. Can we reduce the number of laparoscopies?
  411. OC068: Patient history and ultrasound findings: A logistic regression model for the prediction of pelvic pathology in women with chronic pelvic pain
  412. OC070: Can transvaginal ultrasound detect and localize endometriosis in women with chronic pelvic pain?
  413. OC118: Mathematical models to evaluate ovarian masses?can they beat an expert operator?
  414. OC013: What do you do when you cannot see a pregnancy with ultrasound? The management of pregnancies of unknown location
  415. P113: Can serum hormonal levels predict ectopic pregnancies
  416. OC121: Should we screen for ovarian pathology in the first trimester?
  417. OC190: Should all emergency gynecology patients have an ultrasound scan?
  418. OC197: Transvaginal ultrasound findings in women with moderate to severe pelvic inflammatory disease
  419. OC258: Ovarian cysts in young women?the predictive value of ultrasound for dermoids and endometriomas and managing cysts in early pregnancy
  420. OC018: Should complete miscarriages be followed up with serum human chorionic gonadotrophin levels?
  421. OC198: Should an ectopic pregnancy always be diagnosed using transvaginal ultrasonography in the first trimester prior to surgery?
  422. P112: Is the use of prophylactic antibiotics required in women being managed expectantly with incomplete miscarriage?
  423. OC195: The transvaginal ultrasound based acute gynaecology unit: Short term follow up of women seen with acute pelvic pain
  424. OC016: Can we safely adopt a single visit approach to the management of pregnancies of unknown location?
  425. P390: Suspected gynaecological malignancies?role of ultrasound in a ?fast track? referral clinic
  426. P386: Screening for endometrial cancer in a high-risk population (Hereditary Non Polyposis Colorectal Cancer)?a pilot study
  427. OC232: Screening for familial ovarian cancer?a 10 year observational study
  428. OC159: Reducing surgical intervention with transvaginal ultrasound
  429. Sporadic abnormal vaginal bleeding (intermenstrual, postcoital and postmenopausal bleeding)
  430. Expectant management of incomplete, spontaneous first-trimester miscarriage: outcome according to initial ultrasound criteria and value of follow-up visits
  431. What is the correct primary diagnostic tool in the 'one-stop' clinic for the investigation of abnormal menstrual bleeding?
  432. To the Editor
  433. Transvaginal ultrasonography sonohysterography and operative hysteroscopy for the evaluation of abnormal uterine bleeding
  434. The feasibility of a ‘one stop’ ultrasound-based clinic for the diagnosis and management of abnormal uterine bleeding
  435. The development of the fetal penis-anin uterosonographic evaluation
  436. The characterization of common ovarian cysts in premenopausal women
  437. Transvaginal ultrasonography sonohysterography and operative hysteroscopy for the evaluation of abnormal uterine bleeding
  438. Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) group
  439. Benign Ovarian Cysts and Ovarian Cancer: A Cohort Study With Implications for Screening
  440. The endometrium in breast cancer patients on tamoxifen
  441. Benign ovarian cysts and ovarian cancer: a cohort study with implications for screening
  442. Psychological impact of endometrial monitoring in tamoxifen-treated postmenopausal breast cancer patients
  443. Uterine anomalies and failed surgical termination of pregnancy: the role of routine preoperative transvaginal sonography
  444. The assessment of endometrial pathology and tubal patency: a comparison between the use of ultrasonography and X-ray hysterosalpingography for the investigation of infertility patients
  445. A comparison of methods for preoperative discrimination between malignant and benign adnexal masses: The development of a new logistic regression model
  446. The conservative management of first trimester miscarriages and the use of colour Doppler sonography for patient selection
  447. Lack of evidence from HPLC 32P-post-labelling for tamoxifenDNA adducts in the human endometrium
  448. Sonographic prediction of malignancy in adnexal masses using an artificial neural network
  449. Subjective assessment of adnexal masses with the use of ultrasonography: an analysis of interobserver variability and experience
  450. Artificial neural network models for the preoperative discrimination between malignant and benign adnexal masses
  451. III.2 Saline infusion sonography (SIS) or office hysteroscopy: Which one is the best? A prospective randomised study
  452. VI.6 Detection of DNA adducts in the human endometrium: a lack of evidence
  453. A randomized trial on the use of ultrasonography or office hysteroscopy for endometrial assessment in postmenopausal patients with breast cancer who were treated with tamoxifen
  454. Acute effects of a transdermal nitric oxide donor on perifollicular and intrauterine blood flow
  455. The effects of norethisterone on endometrial abnormalities identified by transvaginal ultrasound screening of healthy post-menopausal women on tamoxifen or placebo
  456. An evaluation of sonohysterography and diagnostic hysteroscopy for the assessment of intrauterine pathology
  457. Comparison of Transvaginal Color Doppler Imaging and Color Doppler Energy for Assessment of Intraovarian Blood Flow
  458. Preovulatory Changes of Blood Flow in Different Regions of the Human Follicle
  459. Screening strategies for ovarian cancer
  460. P106 A lack of evidence for the genotoxicity of tamoxifen and toremifene in the human endometrium
  461. Sonographic prediction of malignancy in adnexal masses using multivariate logistic regression analysis
  462. Ultrasound in gynecology: endometrium
  463. The relationship between preoperative endometrial thickness, the anteroposterior diameter of the uterus and clinical outcome following transcervical resection of the endometrium
  464. F181 Hormone replacement therapy after transcervical resection of the endometrium
  465. Preiinplantation diagnosis: Ultrasound derived indices of follicular blood flow before HCG administration and the prediction of oocyte recovery and preimplantation embryo quality
  466. Hormone replacement therapy after transcervical resection of the endometrium
  467. Ultrasound studies of vascular and morphological changes in the human uterus after a positive self-test for the urinary luteinizing hormone surge
  468. A comparison of intratumoural indices of blood flow velocity and impedance for the diagnosis of ovarian cancer
  469. Associations between ultrasound indices of follicular blood flow, oocyte recovery and preimplantation embryo quality
  470. Evaluating the endometrium of postmenopausal women with transvaginal ultrasonography
  471. Effects of Tamoxifen on Uterus and Ovaries of Postmenopausal Women in a Randomised Breast Cancer Prevention Trial
  472. Transvaginal Colour Doppler
  473. Transvaginal Ultrasonography of Endometrial Disorders in Postmenopausal Women
  474. False positive results in ovarian cancer screening: One year follow-up of psychological status
  475. The potential role of serum CA 125 in an ultrasound-based screening program for familial ovarian cancer
  476. Use of transvaginal ultrasonography with color Doppler imaging to determine an appropriate treatment regimen for uterine fibroids with a GnRH agonist before surgery: a preliminary study
  477. Feasibility Study of a Randomised Trial of Ovarian Cancer Screening among the General Population
  478. Should clinical decisions be made about ovarian masses using transvaginal color Doppler?
  479. Association of ovarian Malignancy With Expression of Paltelet-Derived Endothelial Cell Growth Factor
  480. Effects of tamoxifen on uterus
  481. The use of transvaginal ultrasonography compared to routine gynecological examination to check the location of an intrauterine contraceptive device
  482. Transvaginal color blood flow imaging of the periovulatory follicle
  483. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial
  484. Hysterosalpingo contrast sonography (HyCoSy) and its future role within the investigation of infertility in Europe
  485. A novel technique for measuring bladder wall thickness in women using transvaginal ultrasound
  486. The Potential Role of Serum CA 125 in an Ultrasound-Based Screening Program for Familial Ovarian Cancer
  487. Transvaginal ultrasound-guided ovarian endoscopy: a novel approach to the assessment of ovarian tumors
  488. Use of intracavity saline instillation and transvaginal ultrasonography to detect tamoxifen-associated endometrial polyps
  489. Screening for early familial ovarian cancer with transvaginal ultrasonography and color blood flow imaging
  490. Can Ovarian Masses Be Characterized Using Ultrasound?
  491. Use of family history in a screening clinic for familial ovarian cancer
  492. Screening for ovarian cancer: Authors' reply
  493. Psychological Impact of Screening for Familial Ovarian Cancer
  494. Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging.
  495. Screening for ovarian cancer by transvaginal sonography and colour Doppler
  496. The early detection and assessment of endometrial cancer by transvaginal colour Doppler ultrasonography
  497. Risk of Ovarian Cancer and Genetic Relationship to Other Cancers in Families
  498. Screening for Ovarian Cancer
  499. Reply
  500. A qualitative evaluation of the experience of surgery after false positive results in screening for familial ovarian cancer
  501. Use of family history in a screening clinic for familial ovarian cancer
  502. Ultrasound screening for familial ovarian cancer
  503. Detection of endometrial cancer by transvaginal ultrasonography with color flow imaging and blood flow analysis: A preliminary report
  504. Author's reply
  505. Ultrasound screening for familial ovarian cancer
  506. Paracetamol-associated luteinized unruptured follicle syndrome: effect on intrafollicular blood flow
  507. Transvaginal color Doppler in gynecology
  508. Ovarian cancer screening
  509. Intrafollicular blood flow during human ovulation
  510. Detection of endometrial cancer in postmenopausal women:Authors' reply
  511. Detection of endometrial cancer in postmenopausal women by transvaginal ultrasonography and colour flow imaging.
  512. Detection of early ovarian cancer
  513. Transvaginal colour flow imaging: A possible new screening technique for ovarian cancer
  514. Oestrogens, arterial status, and postmenopausal women
  515. Detection of endometrial cancer by transvaginal ultrasonography with color flow imaging and blood flow analysis: A preliminary report
  516. Transabdominal ultrasound screening for early ovarian cancer: Authors' reply
  517. A comparison of the efficacy of gemeprost vaginal pessaries and extra-amniotic prostaglandin E2 gel in the induction of middle trimester abortion
  518. Failed cuff deftation
  519. Transvaginal colour flow imaging: a possible new screening technique for ovarian cancer.
  520. Ectopic pregnancy
  521. Pelvic utrasound and interventional radiology